tetano
Editor, Senior Moderator
Rhinology
. 2020 Jun 13.
doi: 10.4193/Rhin20.227. Online ahead of print.
Time Scale for Resolution of Olfactory Dysfunction in COVID-19
M M Speth[SUP] 1 [/SUP], T Singer-Cornelius[SUP] 1 [/SUP], M Oberle[SUP] 2 [/SUP], I Gengler[SUP] 3 [/SUP], S J Brockmeier[SUP] 1 [/SUP], A R Sedaghat[SUP] 3 [/SUP]
Affiliations
Abstract
By now, the 2019 novel coronavirus disease (COVID-19), caused by the SARS-CoV-2 virus, is widely recognized around the world as a pandemic that has infected millions and claimed the lives of hundreds of thousands (1). Despite months of mitigation strategies, COVID-19 continues to spread and ascertainment of new knowledge about the disease process continues to be a priority of the medical community. Originally described by characteristic symptoms of fever, cough and/or shortness of breath that can rapidly progress to acute respiratory distress syndrome, it has become clear that COVID-19 has manifold clinical presentations (2-4). Notably, olfactory dysfunction (OD)-decreased sense of smell-has been reported to occur in up to 85.6% of COVID-19 patients (2,5).
. 2020 Jun 13.
doi: 10.4193/Rhin20.227. Online ahead of print.
Time Scale for Resolution of Olfactory Dysfunction in COVID-19
M M Speth[SUP] 1 [/SUP], T Singer-Cornelius[SUP] 1 [/SUP], M Oberle[SUP] 2 [/SUP], I Gengler[SUP] 3 [/SUP], S J Brockmeier[SUP] 1 [/SUP], A R Sedaghat[SUP] 3 [/SUP]
Affiliations
- PMID: 32533768
- DOI: 10.4193/Rhin20.227
Abstract
By now, the 2019 novel coronavirus disease (COVID-19), caused by the SARS-CoV-2 virus, is widely recognized around the world as a pandemic that has infected millions and claimed the lives of hundreds of thousands (1). Despite months of mitigation strategies, COVID-19 continues to spread and ascertainment of new knowledge about the disease process continues to be a priority of the medical community. Originally described by characteristic symptoms of fever, cough and/or shortness of breath that can rapidly progress to acute respiratory distress syndrome, it has become clear that COVID-19 has manifold clinical presentations (2-4). Notably, olfactory dysfunction (OD)-decreased sense of smell-has been reported to occur in up to 85.6% of COVID-19 patients (2,5).